Search for: "WATSON PHARMACEUTICALS "
Results 141 - 160
of 359
Sort by Relevance
|
Sort by Date
18 Apr 2012, 8:15 pm
Watson Pharmaceuticals, Inc., et al. 1:12-cv-00321; filed March 30, 2012 in the Middle District of North Carolina • Plaintiffs: Allergan, Inc.; Duke University • Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
10 Apr 2012, 1:15 pm
The Zarah and Vestura oral contraceptives are made by Watson Pharmaceuticals; and Loryna, a generic version of YAZ, and Syeda, a generic version of Yasmin. [read post]
9 Apr 2012, 5:45 pm
Imagine getting an online medical diagnosis from a smart machine like IBM’s Watson, or learning mathematics from an online MITx program or one of its successors. [read post]
27 Mar 2012, 8:51 am
’s and EGIS Pharmaceuticals PLC’s motions to dismiss AstraZeneca’s claims of infringement of its ‘618 and ‘152 Patents under Section 271(e)(2). [read post]
19 Mar 2012, 1:31 am
Mar. 6, 2012), which concerns metoclopramide, plaintiffs argued that “becoming an RLD at some point for metoclopramide oral solution imbues Teva with NDA duties and liability for metoclopramide tablets,” a pharmaceutically inequivalent drug allegedly ingested by plaintiffs. [read post]
11 Mar 2012, 3:32 pm
Apotex Pty Ltd v AstraZeneca AB (No 2) [2012] FCA 142 (28 February 2012) Watson Pharma Pty Ltd v AstraZeneca AB [2012] FCA 200 (9 March 2012) Interlocutory injunctions – prima facie case – balance of convenience – whether additional evidence provides grounds to vary previous findings At least five Australian pharmaceutical manufacturers are now ready to launch generic versions of cholesterol-lowering drug CRESTOR, while being barred from doing so pending the… [read post]
7 Mar 2012, 12:49 am
On March 7, 2012, Towers Watson released the report of its 2011 Directors and Officers Liability Survey. [read post]
29 Feb 2012, 3:28 am
Watson Pharmaceuticals, Inc., et. al., 3-11-cv-00481 (NVD February 24, 2012, Order) (Jones, J.) [read post]
22 Feb 2012, 7:37 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010) (A company “can readily protect itself by securing a clear written agreement. [read post]
20 Feb 2012, 1:26 am
Drug giant Bayer is suing generic drug manufacturer Watson Pharmaceuticals amid claims that Watson has violated the patent for its birth control pills Beyaz, which is a reformulated version of the drospirenone-based oral contraceptive Yaz/Yasmin. [read post]
19 Feb 2012, 8:55 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories Inc. [read post]
13 Feb 2012, 12:54 pm
Watson Laboratories, Inc., C.A. [read post]
27 Jan 2012, 2:21 pm
A. [read post]
25 Jan 2012, 6:03 am
Following a court order on January 17, Watson Pharmaceuticals has been dismissed as a defendant in several Fosamax lawsuits. [read post]
10 Jan 2012, 12:43 pm
Mamula, Reporter for the Pittsburgh Business Times: Takeda Pharmaceutical, Watson Pharmaceuticals and Andrx Labs have sued generic drugmaker Mylan Inc. for patent infringement in connection with its plans to market pioglitazone hydrochloride and extended release metformin hydrochloride tablets, Canonsburg-based Mylan announced Monday. [read post]
8 Jan 2012, 9:05 pm
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
3 Jan 2012, 2:10 am
This one is made by Watson Pharmaceuticals. [read post]
26 Dec 2011, 1:38 pm
The generic version, called Ventura, is marketed and sold by Watson Pharmaceuticals. [read post]
12 Dec 2011, 5:37 pm
On one side, Watson could identify potential drug targets that could lead to improved research and development for new pharmaceutical drugs. [read post]
4 Dec 2011, 8:52 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. [read post]
